BioMarin (United States)
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
60%
Total
Publications
766
Total Open
Publications
463
Total
Citations
28K
Open Access
Percentage
60%
Total
Publications
766
Total Open
Publications
463
Total
Citations
28K
Breakdown
Publisher Open
17%
Both
34%
Other Platform Open
9%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
143
Hybrid 44%
171
No Guarantees 20%
78
Other Platform Open
Domain 82%
274
Institution 30%
101
Other Internet 11%
37
Preprint 8%
27
Public 7%
24
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 272 |
Europe PMC | Domain | 155 |
University College London - UCL Discovery | Institution | 47 |
Semantic Scholar | Public | 18 |
University of California - eScholarship University of California | Institution | 17 |
bioRxiv | Preprint | 14 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 11 |
Research Square | Preprint | 9 |
California Digital Library - eScholarship | Other Internet | 9 |
Figshare | Public | 8 |